NASDAQ: BGXXBright Green Corp Stock
$0.20+0.00 (+0%)
Updated Apr 24, 2024
BGXX Price
$0.20
Fair Value Price
-$0.03
Market Cap
$37.27M
52 Week Low
$0.15
52 Week High
$1.81
P/E
-2.8x
P/B
3.4x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$13.13M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.59
Operating Cash Flow
-$2M
Beta
0.74
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
BGXX Overview
Bright Green Corporation grows, manufactures, and sells cannabis and cannabis-related products legally under federal and state laws for research, pharmaceutical applications, and export. The company was incorporated in 2019 and is based in Fort Lauderdale, Florida.
Zen Score
–
Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how BGXX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
BGXX ($0.20) is overvalued by 760.67% relative to our estimate of its Fair Value price of -$0.03 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
BGXX ($0.20) is not significantly undervalued (760.67%) relative to our estimate of its Fair Value price of -$0.03 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
BGXX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more BGXX due diligence checks available for Premium users.
Be the first to know about important BGXX news, forecast changes, insider trades & much more!
BGXX News
Valuation
BGXX fair value
Fair Value of BGXX stock based on Discounted Cash Flow (DCF)
Price
$0.20
Fair Value
-$0.03
Undervalued by
774.15%
BGXX ($0.20) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
BGXX ($0.20) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
BGXX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
BGXX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-2.8x
Industry
47.66x
Market
41.27x
BGXX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.4x
Industry
2.06x
BGXX is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
BGXX's financial health
Profit margin
Revenue
$0.0
Net Income
-$5.5M
Profit Margin
0%
BGXX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$17.4M
Liabilities
$6.4M
Debt to equity
0.59
BGXX's short-term liabilities ($6.24M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BGXX's short-term assets ($268.29k) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BGXX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$17.8k
Investing
-$329.5k
Financing
$200.0k
BGXX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
BGXX vs Pharmaceutical Stocks
Bright Green Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.